Bone Marrow Findings of Immune-Mediated Pure Red Cell Aplasia Following Anti-Programmed Cell Death Receptor-1 Therapy: A Report of Two Cases and Review of Literature

Immune checkpoint inhibitors have recently emerged as important and effective advanced cancer treatment options. Programmed cell death receptor-1 (PD-1) antagonists such as pembrolizumab and nivolumab have been approved by the US Food and Drug Administration for treatment of many advanced cancers. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Aye, Le, Harris, James B., Siddiqi, Imran, Hagiya, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153678/
https://www.ncbi.nlm.nih.gov/pubmed/32300448
http://dx.doi.org/10.14740/jh507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153678/
https://www.ncbi.nlm.nih.gov/pubmed/32300448
http://dx.doi.org/10.14740/jh507

Ejemplares similares